INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAB4. A total of 22 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,903,450 | +22.6% | 5,000,000 | 0.0% | 0.02% | +25.0% |
Q2 2023 | $3,998,350 | -3.8% | 5,000,000 | 0.0% | 0.02% | 0.0% |
Q1 2023 | $4,156,550 | +9.8% | 5,000,000 | 0.0% | 0.02% | +11.1% |
Q4 2022 | $3,784,450 | +0.2% | 5,000,000 | 0.0% | 0.02% | +5.9% |
Q3 2022 | $3,777,000 | +17.7% | 5,000,000 | 0.0% | 0.02% | +21.4% |
Q2 2022 | $3,209,000 | +4.6% | 5,000,000 | 0.0% | 0.01% | +16.7% |
Q1 2022 | $3,068,000 | +1.9% | 5,000,000 | 0.0% | 0.01% | +9.1% |
Q4 2021 | $3,012,000 | -0.6% | 5,000,000 | 0.0% | 0.01% | -15.4% |
Q3 2021 | $3,030,000 | -11.4% | 5,000,000 | 0.0% | 0.01% | -18.8% |
Q2 2021 | $3,421,000 | +6.2% | 5,000,000 | 0.0% | 0.02% | -11.1% |
Q1 2021 | $3,220,000 | +6.1% | 5,000,000 | 0.0% | 0.02% | 0.0% |
Q4 2020 | $3,036,000 | -12.4% | 5,000,000 | 0.0% | 0.02% | -18.2% |
Q3 2020 | $3,465,000 | -3.8% | 5,000,000 | 0.0% | 0.02% | -12.0% |
Q2 2020 | $3,602,000 | -17.1% | 5,000,000 | 0.0% | 0.02% | -26.5% |
Q1 2020 | $4,345,000 | -34.7% | 5,000,000 | 0.0% | 0.03% | +3.0% |
Q4 2019 | $6,649,000 | +46.6% | 5,000,000 | 0.0% | 0.03% | +32.0% |
Q3 2019 | $4,537,000 | -9.2% | 5,000,000 | 0.0% | 0.02% | -10.7% |
Q2 2019 | $4,998,000 | – | 5,000,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 55,943,000 | $34,742,000 | 1.33% |
PenderFund Capital Management Ltd. | 5,000,000 | $3,839,000 | 0.98% |
Context Capital Management, LLC | 7,485,000 | $4,494,000 | 0.62% |
Opti Capital Management, LP | 7,000,000 | $4,250,000 | 0.47% |
Soros Fund Management | 32,298,000 | $19,611,000 | 0.37% |
Shaolin Capital Management LLC | 7,000,000 | $4,175,000 | 0.29% |
Weiss Asset Management LP | 3,500,000 | $2,084,000 | 0.09% |
CSS LLC/IL | 2,825,000 | $1,681,000 | 0.06% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 225,000 | $137,000 | 0.02% |
LAZARD ASSET MANAGEMENT LLC | 25,000,000 | $15,009,000 | 0.02% |